The syndrome can also cause severe mental deficiencies in infants. Infants born with phocomelia will normally have a petite head with "sparse hair" that may appear "silvery-blonde." Hemangioma, the abnormal buildup of blood vessels, will possibly develop around the facial area at birth and the eyes may be set widely apart, a condition known as orbital hypertelorism. The pigment of the eyes will be a bluish white. Phocomelia can also cause: an undeveloped nose with slender nostrils, disfigured ears, irregularly petite jaws (a condition known as micrognathia), and a cleft lip with cleft palate. According to NORD, severe symptoms of phocomelia include:
A fissure of the skull and a projecting brain known as (encephalocele)
An accumulation of spinal fluid under the skull also known as hydrocephalus; causing vomiting and migraines
An abnormally shaped uterus (bicornuate)
Inability to clot blood efficiently due to a low amount of platelets running through the blood
Malformations in the kidney and heart
Shortened neck
Abnormalities in the urethra

Thalidomide syndrome symptoms
When an individual is born with phocomelia due to drugs or pharmaceuticals, it is known as thalidomide syndrome. The symptoms of thalidomide syndrome are defined by absent or shortened limbs; causing flipper hands and feet. According to Anthony J Perri III, and Sylvia Hsu they can additionally receive:
Palsy disorder of the face
Ear and eye abnormalities; resulting in limited/complete loss of hearing or sight
Gastrointestinal and genitourinary tract disorders
Ingrown genitalia
Undeveloped/missing lungs
Distorted digestive tract, heart, kidney
disorders to the limbsThe infants that were exposed to thalidomide during development phases had a 40% chance of survival.
DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline. == References ==